Related Experiment Video
Updated: Jul 2, 2026
05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Ischemic Preconditioning And Myocardial Infarction: An Update and Perspective
Eric R Gross1, Garrett J Gross
1Medical College of Wisconsin, Department of Pharmacology and Toxicology, Milwaukee, WI 53226.
Drug Discovery Today. Disease Mechanisms
|August 15, 2008
Summary
Ischemic preconditioning (IPC) offers promising therapeutic strategies against myocardial infarction, the leading cause of death. This review updates on IPC mechanisms, effects in aging/disease models, and potential treatments.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- Myocardial infarction is a primary cause of mortality globally.
- Coronary artery disease incurs substantial healthcare costs.
- Ischemic preconditioning (IPC) research is advancing therapeutics for myocardial injury.
Purpose of the Study:
- To provide an updated review of ischemic preconditioning (IPC).
- To discuss the mechanisms and therapeutic potential of IPC in cardiac conditions.
- To summarize current and future research directions in cardiac IPC.
Main Methods:
- Literature review of preclinical and clinical studies on IPC.
- Analysis of molecular and general mechanisms underlying IPC.
- Evaluation of IPC's effects in aging and disease models.
Main Results:
- IPC involves complex molecular pathways conferring cardioprotection.
- IPC demonstrates efficacy in mitigating myocardial injury in various models.
- Several therapeutics based on IPC show promise in trials.
Conclusions:
- IPC represents a significant area for developing novel treatments for myocardial infarction.
- Further research into IPC mechanisms and clinical translation is warranted.
- Targeting IPC pathways could revolutionize cardiac care.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...